| 000 | 01556 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250514034106.0 | ||
| 264 | 0 | _c20020708 | |
| 008 | 200207s 0 0 eng d | ||
| 022 | _a0022-5347 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGoebell, Peter J | |
| 245 | 0 | 0 |
_aEvaluation of an unconventional treatment modality with mistletoe lectin to prevent recurrence of superficial bladder cancer: a randomized phase II trial. _h[electronic resource] |
| 260 |
_bThe Journal of urology _cJul 2002 |
||
| 300 |
_a72-5 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Comparative Study; Evaluation Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aCarcinoma, Transitional Cell _xdrug therapy |
| 650 | 0 | 4 | _aChemotherapy, Adjuvant |
| 650 | 0 | 4 | _aCombined Modality Therapy |
| 650 | 0 | 4 | _aCystoscopy |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInjections, Subcutaneous |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNeoplasm Recurrence, Local _xdrug therapy |
| 650 | 0 | 4 | _aNeoplasm Staging |
| 650 | 0 | 4 | _aPhytotherapy |
| 650 | 0 | 4 | _aPlant Preparations |
| 650 | 0 | 4 | _aPlant Proteins |
| 650 | 0 | 4 | _aRibosome Inactivating Proteins, Type 2 |
| 650 | 0 | 4 | _aSurvival Rate |
| 650 | 0 | 4 |
_aToxins, Biological _xtherapeutic use |
| 650 | 0 | 4 |
_aUrinary Bladder Neoplasms _xdrug therapy |
| 700 | 1 | _aOtto, Thomas | |
| 700 | 1 | _aSuhr, Julia | |
| 700 | 1 | _aRübben, Herbert | |
| 773 | 0 |
_tThe Journal of urology _gvol. 168 _gno. 1 _gp. 72-5 |
|
| 999 |
_c11946746 _d11946746 |
||